CN113101050A - Health-care eye patch capable of effectively relieving eyestrain and manufacturing method thereof - Google Patents
Health-care eye patch capable of effectively relieving eyestrain and manufacturing method thereof Download PDFInfo
- Publication number
- CN113101050A CN113101050A CN202110334468.4A CN202110334468A CN113101050A CN 113101050 A CN113101050 A CN 113101050A CN 202110334468 A CN202110334468 A CN 202110334468A CN 113101050 A CN113101050 A CN 113101050A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- eye
- eye patch
- pressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000003464 asthenopia Diseases 0.000 title claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- 230000036541 health Effects 0.000 claims abstract description 41
- 239000003814 drug Substances 0.000 claims abstract description 35
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 10
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 5
- 238000003825 pressing Methods 0.000 claims description 16
- 244000136948 Ocimum sanctum Species 0.000 claims description 13
- 235000004072 Ocimum sanctum Nutrition 0.000 claims description 13
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 12
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 12
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 12
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 10
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 10
- 241000382455 Angelica sinensis Species 0.000 claims description 9
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 9
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 9
- 244000124209 Crocus sativus Species 0.000 claims description 9
- 235000015655 Crocus sativus Nutrition 0.000 claims description 9
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 9
- 244000182216 Mimusops elengi Species 0.000 claims description 9
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 9
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 claims description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 8
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 8
- 241000037740 Coptis chinensis Species 0.000 claims description 8
- 241000159213 Zygophyllaceae Species 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 235000009165 saligot Nutrition 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 240000000031 Achyranthes bidentata Species 0.000 claims description 7
- 241000972672 Phellodendron Species 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 4
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 4
- 244000061520 Angelica archangelica Species 0.000 claims description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 4
- 229940116229 borneol Drugs 0.000 claims description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 230000001965 increasing effect Effects 0.000 claims description 4
- 229960003639 laurocapram Drugs 0.000 claims description 4
- 235000013974 saffron Nutrition 0.000 claims description 4
- 239000004248 saffron Substances 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 241000218202 Coptis Species 0.000 claims description 3
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 241000427159 Achyranthes Species 0.000 claims description 2
- 241000628997 Flos Species 0.000 claims description 2
- 206010020843 Hyperthermia Diseases 0.000 claims description 2
- 244000110797 Polygonum persicaria Species 0.000 claims description 2
- 235000004442 Polygonum persicaria Nutrition 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 claims description 2
- 230000036031 hyperthermia Effects 0.000 claims description 2
- 239000004745 nonwoven fabric Substances 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 206010049565 Muscle fatigue Diseases 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000003287 optical effect Effects 0.000 abstract description 3
- 210000004185 liver Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000004438 eyesight Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 206010023644 Lacrimation increased Diseases 0.000 description 6
- 241000972673 Phellodendron amurense Species 0.000 description 6
- 230000004317 lacrimation Effects 0.000 description 6
- 230000004089 microcirculation Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010013774 Dry eye Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010034960 Photophobia Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000005282 brightening Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- 230000004379 myopia Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 208000005494 xerophthalmia Diseases 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010047571 Visual impairment Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000010015 huanglian Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000000015 thermotherapy Methods 0.000 description 2
- 241000208173 Apiaceae Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011026 Corneal lesion Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010015967 Eye swelling Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241001571736 Lysimachia foenum-graecum Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000208476 Primulaceae Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241001521901 Tribulus lanuginosus Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000029444 double vision Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008472 epithelial growth Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 210000001145 finger joint Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000008738 huangbai Substances 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 229960005321 mecobalamin Drugs 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 1
- 235000007672 methylcobalamin Nutrition 0.000 description 1
- 239000011585 methylcobalamin Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000018962 mouth sore Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/04—Eye-masks ; Devices to be worn on the face, not intended for looking through; Eye-pads for sunbathing
- A61F9/045—Eye-shades or visors; Shields beside, between or below the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A health eye patch capable of effectively relieving eyestrain and a manufacturing method thereof relate to the technical field of eye health care products and comprise an eyeshade and a health eye protection frame arranged on the eyeshade, wherein tightening ear wings are arranged on two sides of a main body of the health eye patch and connected through elastic bands, and a traditional Chinese medicine layer, an electromagnetic thermal therapy layer, a graphene optical wave layer and a thermomagnetic narrow wave are sequentially arranged on the inner side of a body of the health eye patch; the invention has the beneficial effects that: it has effects in improving blood circulation, relieving muscle fatigue, dispelling cold, and eliminating dampness.
Description
Technical Field
The invention relates to the technical field of eye health care products, in particular to a health care eye patch capable of effectively relieving eyestrain and a manufacturing method thereof.
Background
In recent years, with the change of information communication modes and the acceleration of work, study and life rhythm, the eye load is increased, and the number of visual fatigue patients in the crowd tends to increase gradually. This trend is particularly evident in people using video display terminals such as computers, televisions, monitors, electronic game machines, because of the particularities of the use environment affecting the visual function. It is reported that 10% to 15% of subjects who were subjected to the conventional ophthalmologic examination had headache and asthenopia due to computer work, and about 33.5% of VDT operators had complaint with a growing tendency. More and more people begin to complain of redness, dryness, distending pain, etc. of the eyes, but only a very few recognize the hazards of asthenopia. In fact, if asthenopia occurs frequently, vision deteriorates and the eyes age in advance.
The symptoms of asthenopia include asthenopia, dry eye, foreign body sensation, heavy eyelid, blurred vision, photophobia, lacrimation, eye swelling and pain, hyperemia of eyes, etc., severe patients can also have general symptoms of headache, dizziness, nausea, listlessness, inattention, memory decline, inappetence, aching pain of neck, shoulder, waist and back, numbness of finger joints, etc., a few patients can have double vision, stereoscopic vision dysfunction, increased intraocular pressure, corneal lesion, etc., and teenagers can also have myopia or deepen original myopia. Patients with glaucoma, ocular surface or anterior segment disease may also develop or aggravate the underlying ocular condition due to excessive eye fatigue. The asthenopia is a common disease in ophthalmology at present, and seriously affects the life of people. It is not an independent disease, but a group of fatigue syndromes due to various causes. At present, the health care methods comprise physical therapies such as prism correction, operation health care, acupuncture and moxibustion and the like; the chemical medicines mostly adopt parasympathetic nerve stimulants such as receptor blockers mecobalamin and the like, nerve nutritional agents, sedatives and the like, in addition, the situation is relieved by eye patches or massage health care and other modes, the massage health care effect is not good because many people do not have time, most of the existing eye patches are made of related medicines for protecting eyes and improving asthenopia, but most of the products do not clearly define effective active ingredients in related products, the content of the effective ingredients is relatively low and the absorption is slow, and the products contain heavy metal ions and the like due to the addition of artificial preservatives in individual products, so that the eye discomfort is easily caused, and the occurrence of the asthenopia is accelerated.
Disclosure of Invention
Aiming at the defects and shortcomings of the prior art, the eye discomfort symptom can be effectively improved, the effective components directly act on the eyes, the nutrition required by the eyes is supplemented, the microcirculation of the eyeground is improved, the heat is reduced, the liver is calmed, the flame is extinguished, and the liver is cleared and the eyesight is improved. Has the effects of preventing and protecting health of xerophthalmia, protecting eyes, brightening eyes and the like.
In order to achieve the purpose, the invention adopts the following technical scheme: a health eye patch capable of effectively relieving eyestrain comprises an eyeshade 1 and a health eye protection frame 3 arranged on the eyeshade 1, wherein tightening ear wings 4 are arranged on two sides of a health eye patch main body 3, the tightening ear wings 4 are connected through elastic bands 2, and a traditional Chinese medicine layer 31, an electromagnetic thermal therapy layer 32, a graphene optical wave layer 33 and a thermomagnetic narrow wave 34 are sequentially arranged on the inner side of a health eye patch main body 3; the traditional Chinese medicine layer 31 is prepared from 1-3 parts of coptis chinensis, 1-3 parts of angelica sinensis, 1-3 parts of salvia miltiorrhiza, 1-3 parts of holy basil, 1-3 parts of mint, 1-3 parts of phellodendron amurense, 1-3 parts of saffron crocus, 1-3 parts of medlar, 1-3 parts of achyranthes bidentata, 1-3 parts of tribulus terrestris, 1-3 parts of fructus polygoni orientalis, 1-3 parts of semen cassiae and 1-3 parts of chrysanthemum, a storage battery is arranged in the electromagnetic thermotherapy layer 32, and the graphene light wave layer 33 is a graphene heating film.
The preparation method of the traditional Chinese medicine layer 31 comprises the following steps:
weighing Coptidis rhizoma, radix Angelicae sinensis, Saviae Miltiorrhizae radix, herba Lysimachiae Foenumgraeci, herba Menthae, cortex Phellodendri, stigma croci Sativi, fructus Lycii, Achyranthis radix, fructus Tribuli, fructus Polygoni orientalis, semen Cassiae, and flos Chrysanthemi, and drying the above materials;
step two, placing the medicine dried in the step one in a low-temperature storage device, breaking the wall at a low temperature for 12 hours, taking out, and cooling to the normal temperature;
step three, putting the medicine cooled in the step two into distilled water, soaking for 1-3 h, and heating to 100 ℃;
taking out the medicines in the third step, putting the medicines into a pressure change storage device, and performing vacuum wall breaking extraction to obtain extract liquor;
step five, taking out the extract liquid in the step four, and adding borneol for dissolving;
taking out the liquid medicine, adding the laurocapram water molecule skin penetrating agent, adding the emulsifier, stirring, fully fusing water and oil, soaking the non-woven fabric subjected to high-pressure sterilization in the eye protection liquid medicine for 0.5-1 h, then sterilizing by a radio frequency technology, and packaging to obtain the health care eye mask.
Further, the coptis chinensis, the angelica sinensis, the salvia miltiorrhiza, the holy basil, the mint, the golden cypress, the saffron, the medlar, the achyranthes bidentata, the caltrop, the princesplume ladysthumb fruit, the cassia seed and the chrysanthemum are weighed according to the weight ratio of 1:1:1:1:1: 1.
Further, the temperature of the low-temperature storage in the second step is any one of-50 ℃, 30 ℃ or 80 ℃.
Further, the pressure of the pressure change storage in the third step is 4-11 MPa.
Further, the vacuum degree of vacuum wall breaking in the third step is 0.08-0.15 MPa.
Furthermore, the weight ratio of the extract liquid in the fifth step to the borneol is 5-8: 1.
Furthermore, the liquid medicine in the sixth step is laurocapram water molecule and emulsifier which are 6:1:1 to 9:1: 1.
Use of the electromagnetic hyperthermia layer 32:
step one, a voltage of 220v is switched in, a buzzer sounds, a power supply lamp is turned on, a nixie tube displays 00,
step two, setting the health care time: pressing the time button to set time, increasing the time by 10 minutes at most to 90 minutes, pressing again to 00,
step three, setting temperature: after pressing the 'temperature' button, if the nixie tube displays 10, the power is 100%, then pressing the display 9, the power is 90%, then pressing once again reduces the power by 10%, until 5, the power is 50%, then pressing back, the nixie tube displays 10, the power is 100%,
step three, pressing an on/off button, turning on a work indicating lamp, starting to count down, ending the time (displaying 00), turning off the work indicating lamp, sounding a buzzer, ending the health care,
step four, resetting time and temperature, and starting next health care again according to' on/off
Step five, in the heating health care, the health care can be stopped by pressing an 'on/off' button.
In the Chinese medicine layer 31, Huanglian is also known as Wang Lian and Zhilian. Nature and taste: bitter and cold. Huanglian is a commonly used Chinese medicine, listed as the top grade in Shen nong Ben Cao Jing, so its root is named "Lianzhu with yellow color". Coptidis rhizoma has antiinflammatory and antipyretic effects, and can be used for treating conjunctival congestion and aphtha. Our ancestors have used coptis to treat eye diseases as early as a thousand years ago. According to records of Shennong herbal, the coptis root is bitter and cold in taste, the main heat and eye pain, the angular injury and the tear are caused, and the eyesight is improved. The radix Angelicae sinensis is dried root of Angelica sinensis (oliv.) Diels of Umbelliferae. Dang Gui is sweet and pungent in flavor and warm in nature. It enters liver, heart and spleen channels, and has effects of invigorating qi, replenishing blood, and protecting liver. Traditional Chinese medicine has a sentence name: the ten prescriptions and nine returning prescriptions. The Chinese angelica is said to be the Chinese angelica. It is worth mentioning that angelica is a good product for beautifying, whitening and resisting aging. The water solution of radix Angelicae sinensis has strong tyrosinase activity inhibiting effect, is a killer mace for treating chloasma and freckle, and can make skin tender and glossy. The salvia miltiorrhiza is bitter and slightly pungent in taste and slightly cold in nature, and has the effects of activating blood circulation to dissipate blood stasis, nourishing blood to calm the nerves, cooling blood and relieving swelling. Modern medicine finds that some children have myopia at around 10 years of age, up to 400 degrees or more, resulting in early stage ocular vascular occlusion. The eye patch for golden vision is added with Saviae Miltiorrhizae radix to improve microcirculation, so as to control disease condition and prevent deterioration. Holy basil is a plant of the primrose family, with strong fragrance, also called vanilla, lysimachia foenum-graecum hance, Pinnan aroma, Guang holy basil. Pungent and sweet with warm taste. Dispelling wind and relieving exterior syndrome; resolving dampness and regulating the middle warmer; promoting qi and blood circulation; detoxify and detumescence. The medicinal history of the holy basil is very long, and the holy basil is recorded in a plurality of long-term medical classics. The bibliographic records are: "improving eyesight and stopping tear, removing foul and bad breath, fever, headache, ascending qi and lumbago". Mint is pungent and cool. Enter lung and liver meridians. Has effects in refreshing, relieving depression, relieving fatigue, dispelling pathogenic wind, inducing perspiration, relieving inflammation, relieving itching, preventing putrefaction, and removing fishy smell. In addition to these well known effects, peppermint, also known as "Eyegrass", is used to treat ophthalmic conditions. Traditional Chinese medicine believes that the liver opens into eyes, blood can be obtained from eyes, and mint has the efficacy of soothing liver and removing blood stasis. The Chinese pharmacopoeia records that the mint has the main functions of dispelling wind heat and clearing head and eyes. "Huangbai is bark of phellodendron amurense Rupr or phellodendron amurense Rupr of Rutaceae. Bitter in property and cold in nature. Phellodendron bark, cortex Phellodendri clears heat and dampness, purges fire and removes toxicity, removes bone-steaming and clears deficiency heat. The phellodendron bark has long medicinal history and wide application. At home and abroad, the medical community generally considers that the phellodendron bark is the top grade of the medicinal materials for clearing heat and drying dampness. The "Rihuazi materia Medica" records: "Anxin Jilao", treating steaming bone, washing liver, improving vision, lacrimation and dry mouth. "Biyu" records: treating infantile convulsion in the skin, hot and red eyes and mouth sores. "
The electromagnetic thermotherapy layer 32 can promote the organism to absorb various deficient elements, repair and dredge the microcirculation channel; the immunity and disease resistance of the organism are stimulated; promoting the secretion of enkephalin and reaching the aim of continuous analgesia. The treatment results of more than 20 years of clinical treatment for hundreds of millions of people fully show that the electromagnetic wave therapeutic apparatus has the following advantages: anti-inflammatory, analgesic, antipruritic, blood lipid reducing, microcirculation dredging, deep blood stasis removing, epithelial growth promoting, and wound healing promoting effects, and has no toxic and side effects.
The graphene light wave layer 33 heating film is converted into heat energy under the electric action. In the process, far infrared and negative ions can be continuously released, and the thermoelectric stimulation effect of micro-current is brought to the human body. Thereby improving blood circulation, relieving muscle fatigue, dispelling cold and eliminating dampness.
After the technical scheme is adopted, the invention has the beneficial effects that: can effectively improve the discomfort symptom of the eyes, lead the effective components to directly act on the eyes, supplement the nutrition required by the eyes, improve the microcirculation of the eyeground, clear heat and lower fire, calm the liver and extinguish the fire, clear the liver and improve the eyesight. Has the effects of preventing and protecting health of xerophthalmia, protecting eyes, brightening eyes and the like. Meanwhile, the eye care product has obvious curative effects on vision-deteriorated persons such as eye acerbity, pain, lacrimation, computer terminal syndrome and the like caused by asthenopia, can improve or relieve asthenopia symptoms such as visual disturbance, eye drowsiness, photophobia, ache, lacrimation, foreign body sensation, eye dryness, eye spasm and the like, and has good conditioning curative effects. The graphene light wave layer heating film is converted into heat energy under the action of electricity. In the process, far infrared and negative ions can be continuously released, and the thermoelectric stimulation effect of micro-current is brought to the human body. Thereby improving blood circulation, relieving muscle fatigue, dispelling cold and eliminating dampness.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention and not to limit the invention. In the drawings:
FIG. 1 is a schematic view of the overall structure of the present invention;
FIG. 2 is an enlarged view of the region A of the present invention.
In the figure: the eyeshade comprises an eyeshade 1, an elastic band 2, a health-care eyeshade frame 3, a tightening ear wing 4, a traditional Chinese medicine layer 31, an electromagnetic thermal therapy layer 32, a graphene light wave layer 33 and a thermomagnetic narrow wave 34.
Detailed Description
Example 1
The technical scheme adopted by the specific implementation mode is as follows: a health eye patch capable of effectively relieving eyestrain comprises an eyeshade 1 and a health eye protection frame 3 arranged on the eyeshade 1, wherein tightening ear wings 4 are arranged on two sides of a health eye patch main body 3, the tightening ear wings 4 are connected through elastic bands 2, and a traditional Chinese medicine layer 31, an electromagnetic thermal therapy layer 32, a graphene optical wave layer 33 and a thermomagnetic narrow wave 34 are sequentially arranged on the inner side of a health eye patch main body 3; the traditional Chinese medicine layer 31 is composed of the following raw materials in parts by weight: 1 part of coptis chinensis, 1 part of angelica, 1 part of salvia miltiorrhiza, 1 part of holy basil, 1 part of mint, 1 part of phellodendron, 1 part of saffron, 1 part of medlar, 1 part of achyranthes, 1 part of caltrop, 1 part of fructus polygoni orientalis, 1 part of cassia seed and 1 part of chrysanthemum.
Example 2
The present embodiment is different from embodiment 1 in that: the traditional Chinese medicine layer 31 is composed of the following raw materials in parts by weight: 2 parts of coptis chinensis, 2 parts of angelica sinensis, 2 parts of salvia miltiorrhiza, 2 parts of holy basil, 2 parts of mint, 2 parts of phellodendron, 2 parts of saffron crocus, 2 parts of medlar, 2 parts of achyranthes bidentata, 2 parts of caltrop, 2 parts of fructus polygoni orientalis, 2 parts of cassia seed and 2 parts of chrysanthemum, and the preparation methods are the same as those in example 1.
Example 3
The present embodiment is different from embodiment 1 in that: the traditional Chinese medicine layer 31 is composed of the following raw materials in parts by weight: 3 parts of coptis chinensis, 3 parts of angelica sinensis, 3 parts of salvia miltiorrhiza, 3 parts of holy basil, 3 parts of mint, 3 parts of phellodendron, 3 parts of saffron crocus, 3 parts of medlar, 3 parts of achyranthes bidentata, 3 parts of caltrop, 3 parts of fructus polygoni orientalis, 3 parts of cassia seed and 3 parts of chrysanthemum, and the preparation methods are the same as those in example 1.
After the technical scheme is adopted, the invention has the beneficial effects that: can effectively improve the discomfort symptom of the eyes, lead the effective components to directly act on the eyes, supplement the nutrition required by the eyes, improve the microcirculation of the eyeground, clear heat and lower fire, calm the liver and extinguish the fire, clear the liver and improve the eyesight. Has the effects of preventing and protecting health of xerophthalmia, protecting eyes, brightening eyes and the like. Meanwhile, the eye care product has obvious curative effects on vision-deteriorated persons such as eye acerbity, pain, lacrimation, computer terminal syndrome and the like caused by asthenopia, can improve or relieve asthenopia symptoms such as visual disturbance, eye drowsiness, photophobia, ache, lacrimation, foreign body sensation, eye dryness, eye spasm and the like, and has good conditioning curative effects. The graphene light wave layer heating film is converted into heat energy under the action of electricity. In the process, far infrared and negative ions can be continuously released, and the thermoelectric stimulation effect of micro-current is brought to the human body. Thereby improving blood circulation, relieving muscle fatigue, dispelling cold and eliminating dampness.
The above description is only for the purpose of illustrating the technical solutions of the present invention and not for the purpose of limiting the same, and other modifications or equivalent substitutions made by those skilled in the art to the technical solutions of the present invention should be covered within the scope of the claims of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
Claims (7)
1. A health eye patch capable of effectively relieving eyestrain and a manufacturing method thereof are characterized by comprising an eyeshade 1 and a health eye protection frame 3 arranged on the eyeshade 1, wherein tightening ear wings 4 are arranged on two sides of the health eye patch main body 3, the tightening ear wings 4 are connected through elastic bands 2, and a traditional Chinese medicine layer 31, an electromagnetic thermal therapy layer 32, a graphene light wave layer 33 and a thermomagnetic narrow wave 34 are sequentially arranged on the inner side of the health eye patch main body 3.
2. A health eye patch capable of effectively relieving asthenopia and a manufacturing method thereof are characterized in that: the preparation method of the traditional Chinese medicine layer 31 comprises the following steps:
weighing Coptidis rhizoma, radix Angelicae sinensis, Saviae Miltiorrhizae radix, herba Lysimachiae Foenumgraeci, herba Menthae, cortex Phellodendri, stigma croci Sativi, fructus Lycii, Achyranthis radix, fructus Tribuli, fructus Polygoni orientalis, semen Cassiae, and flos Chrysanthemi, and drying the above materials;
step two, placing the medicine dried in the step one in a low-temperature storage device, breaking the wall at a low temperature for 12 hours, taking out, and cooling to the normal temperature;
step three, putting the medicine cooled in the step two into distilled water, soaking for 1-3 h, and heating to 100 ℃;
taking out the medicines in the third step, putting the medicines into a pressure change storage device, and performing vacuum wall breaking extraction to obtain extract liquor;
step five, taking out the extract liquid in the step four, and adding borneol for dissolving;
taking out the liquid medicine, adding the laurocapram water molecule skin penetrating agent, adding the emulsifier, stirring, fully fusing water and oil, soaking the non-woven fabric subjected to high-pressure sterilization in the eye protection liquid medicine for 0.5-1 h, then sterilizing by a radio frequency technology, and packaging to obtain the health care eye mask.
Use of the electromagnetic hyperthermia layer 32:
step one, a voltage of 220v is switched in, a buzzer sounds, a power supply lamp is turned on, a nixie tube displays 00,
step two, setting the health care time: pressing the time button to set time, increasing the time by 10 minutes at most to 90 minutes, pressing again to 00,
step three, setting temperature: after pressing the 'temperature' button, if the nixie tube displays 10, the power is 100%, then pressing the display 9, the power is 90%, then pressing once again reduces the power by 10%, until 5, the power is 50%, then pressing back, the nixie tube displays 10, the power is 100%,
step three, pressing an on/off button, turning on a work indicating lamp, starting to count down, ending the time (displaying 00), turning off the work indicating lamp, sounding a buzzer, ending the health care,
step four, resetting time and temperature, and starting next health care again according to' on/off
Step five, in the heating health care, the health care can be stopped by pressing an 'on/off' button.
3. A health-care eye patch capable of effectively relieving eyestrain according to claim 1, wherein the traditional Chinese medicine layer 31 is composed of the following raw materials in parts by weight: 1 part of coptis chinensis, 1 part of angelica, 1 part of salvia miltiorrhiza, 1 part of holy basil, 1 part of mint, 1 part of phellodendron, 1 part of saffron, 1 part of medlar, 1 part of achyranthes, 1 part of caltrop, 1 part of fructus polygoni orientalis, 1 part of cassia seed and 1 part of chrysanthemum.
4. A health-care eye patch capable of effectively relieving eyestrain according to claim 1, wherein the traditional Chinese medicine layer 31 is composed of the following raw materials in parts by weight: 2 parts of coptis chinensis, 2 parts of angelica sinensis, 2 parts of salvia miltiorrhiza, 2 parts of holy basil, 2 parts of mint, 2 parts of phellodendron, 2 parts of saffron crocus, 2 parts of medlar, 2 parts of achyranthes bidentata, 2 parts of caltrop, 2 parts of fructus polygoni orientalis, 2 parts of cassia seed and 2 parts of chrysanthemum, and the preparation methods are the same as those in example 1.
5. A health eye patch effective in relieving asthenopia according to claim 1, wherein the traditional Chinese medicine layer 31 comprises the following raw materials in parts by weight: 3 parts of coptis chinensis, 3 parts of angelica sinensis, 3 parts of salvia miltiorrhiza, 3 parts of holy basil, 3 parts of mint, 3 parts of phellodendron, 3 parts of saffron crocus, 3 parts of medlar, 3 parts of achyranthes bidentata, 3 parts of caltrop, 3 parts of fructus polygoni orientalis, 3 parts of cassia seed and 3 parts of chrysanthemum, and the preparation methods are the same as those in example 1.
6. The coptis, the angelica, the salvia miltiorrhiza, the holy basil, the mint, the phellodendron, the saffron, the medlar, the achyranthes bidentata, the caltrop, the princesplume ladysthumb fruit, the cassia seed and the chrysanthemum are weighed according to the weight ratio of 1:1:1:1:1: 1.
7. The eye mask for health care capable of effectively relieving eyestrain according to claim 2, characterized in that: the temperature of the low-temperature reservoir in the second step of the traditional Chinese medicine layer 31 is any one of-50 ℃, 30 ℃ or 80 ℃, the pressure of the pressure change reservoir in the third step is 4-11 MPa, the vacuum degree of vacuum wall breaking in the third step is 0.08-0.15 MPa, the weight ratio of the extraction liquid and the borneol in the fifth step is 5-8: 1, and the weight ratio of laurocapram to the emulsifier is 6:1: 1-9: 1: 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110334468.4A CN113101050A (en) | 2021-03-29 | 2021-03-29 | Health-care eye patch capable of effectively relieving eyestrain and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110334468.4A CN113101050A (en) | 2021-03-29 | 2021-03-29 | Health-care eye patch capable of effectively relieving eyestrain and manufacturing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113101050A true CN113101050A (en) | 2021-07-13 |
Family
ID=76712905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110334468.4A Pending CN113101050A (en) | 2021-03-29 | 2021-03-29 | Health-care eye patch capable of effectively relieving eyestrain and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113101050A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2802542Y (en) * | 2005-06-21 | 2006-08-02 | 付耀华 | Glasses with magnetic therapy sheet |
CN202119997U (en) * | 2011-05-09 | 2012-01-18 | 董添一 | Anti-fatigue glasses |
CN205626262U (en) * | 2016-03-21 | 2016-10-12 | 佛山市顺德区三北电子有限公司 | Cover glass with role of physical therapy |
CN206964728U (en) * | 2016-09-21 | 2018-02-06 | 烯旺新材料科技股份有限公司 | Heating eye patch |
CN207693769U (en) * | 2017-06-27 | 2018-08-07 | 广东富琳健康产业有限公司 | A kind of intelligent nano Graphene antibiosis health-care physiotherapeutic eyeshade |
-
2021
- 2021-03-29 CN CN202110334468.4A patent/CN113101050A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2802542Y (en) * | 2005-06-21 | 2006-08-02 | 付耀华 | Glasses with magnetic therapy sheet |
CN202119997U (en) * | 2011-05-09 | 2012-01-18 | 董添一 | Anti-fatigue glasses |
CN205626262U (en) * | 2016-03-21 | 2016-10-12 | 佛山市顺德区三北电子有限公司 | Cover glass with role of physical therapy |
CN206964728U (en) * | 2016-09-21 | 2018-02-06 | 烯旺新材料科技股份有限公司 | Heating eye patch |
CN207693769U (en) * | 2017-06-27 | 2018-08-07 | 广东富琳健康产业有限公司 | A kind of intelligent nano Graphene antibiosis health-care physiotherapeutic eyeshade |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103610947B (en) | Medicament for treating prosopospasm and preparation method thereof | |
CN103768283A (en) | Traditional Chinese medicine for treating multiple eye diseases | |
CN103316146A (en) | Traditional Chinese medicinal preparation for anesthesia | |
CN111035748A (en) | Traditional Chinese medicine composition for improving myopia, external application preparation for improving myopia and eye patch for improving myopia | |
CN106334107A (en) | Traditional Chinese medicine eye drops and preparation method thereof | |
CN109876050A (en) | Compound astragalus membranaceus liquid | |
CN105288208A (en) | Traditional Chinese medicine composition for treating acute optic neuritis | |
CN104547621A (en) | Eye protection traditional Chinese medicine | |
CN101129820A (en) | Orally taken traditional Chinese medicine composition for treating neurasthenia | |
CN104189307A (en) | Traditional Chinese medicine for treating deafness and tinnitus and preparation method thereof | |
CN113101050A (en) | Health-care eye patch capable of effectively relieving eyestrain and manufacturing method thereof | |
CN106362089A (en) | External medicine for treating eye diseases | |
CN102920911B (en) | Traditional Chinese medicine for treating keratoconjunctivitis sicca and preparation method thereof | |
CN103405637B (en) | Drug for treating neurosis and preparation method thereof | |
CN111888450A (en) | Foot bath medicine composition for preventing and treating female cold stagnation and blood stasis dysmenorrhea and preparation method thereof | |
CN105194427A (en) | Traditional Chinese medicine composition for treating xerophthalmia and preparation method of traditional Chinese composition | |
CN110585356A (en) | Traditional Chinese medicine formula for improving eyesight of teenagers and using method | |
CN101301447B (en) | Chinese medicinal composition for treating epilepsy | |
CN104398712A (en) | Chinese medicinal preparation for treating facial spasm and preparation method | |
CN115089633B (en) | Composition for preventing and treating myopia, eye mask and preparation method | |
CN115350230B (en) | Prescription and preparation for preventing myopia | |
CN102935162A (en) | Pills for retrobulbar neuritis and preparation method | |
CN102579724B (en) | Chinese medicine composition for treating glaucoma | |
CN106491730A (en) | A kind of treat Chinese medicine composition of glaucoma and preparation method thereof | |
CN105796749A (en) | Acupoint massage and traditional Chinese medicine composition for relieving asthenopia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210713 |
|
RJ01 | Rejection of invention patent application after publication |